Cannabis strain labels like "indica" and "sativa" don't reliably predict chemical content

Distinct chemical phenotypes (chemotypes) were reliably present across commercial cannabis samples, but commercial labels (strain names, indica/sativa designations) did not consistently align with the observed chemical diversity, though certain labels showed biased associations with specific chemotypes.

Analyzed cannabinoid and terpene content of commercial cannabis samples across six US states. Compared observed phytochemical diversity to commercial labels. Identified chemotype clusters and assessed label-chemotype alignment.

Millions of consumers choose cannabis products based on strain names and indica/sativa labels that this study shows are unreliable predictors of what they are actually consuming, which has implications for both recreational and medical users.

As the cannabis industry matures, this research argues for moving toward chemotype-based labeling systems that tell consumers what is actually in their product, rather than relying on traditional nomenclature with little scientific basis.

The study examined available commercial products, which may not represent all cannabis varieties. Terpene and cannabinoid profiles can be affected by growing conditions, harvest timing, and storage, introducing variability beyond genetics.